Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
Premade Virus Particles
Ready-to-Use | High Titer | Versatile Applications
Premade AAV, adenovirus, lentivirus particles, safe, stable, in stock.
Virus-Like Particles (VLPs)
Stable | Scalable | Customizable
Advanced VLPs for vaccine development (Chikungunya, Dengue, SARS-CoV-2), gene therapy (AAV1 & AAV9), and drug screening (SSTR2, CCR5).
Oligonucleotide Products
Precise | High Yield | Tailored Solutions
Accelerate your research with cost-effective LncRNA qPCR Array Technology.
RNA Interference Products
Targeted | Potent | High Specificity
Human Druggable Genome siRNA Library enables efficient drug target screening.
Recombinant Drug Target Proteins
Authentic | Versatile | Accelerated
Providing functional, high-purity recombinant proteins—including membrane proteins and nanodiscs—to overcome bottlenecks in drug screening and target validation.
Clones
Validated | Reliable | Comprehensive Collection
Ready-to-use clones for streamlined research and development.
Kits
Complete | Convenient | High Sensitivity
Chromogenic LAL Endotoxin Assay Kit ensures precise, FDA-compliant endotoxin quantification for biosafety testing.
Enzymes
Purified | Stable | Efficient
Powerful Tn5 Transposase for DNA insertion and random library construction.
Aptamers
Highly Specific | Robust | Versatile
Aptamers for key proteins like ACVR1A, Akt, EGFR, and VEGFR.
Adjuvants
Enhancing | Synergistic | Effective
Enhance immune responses with high-purity, potent CpG ODNs.
Laboratory Equipment
Innovative | Reliable | High-Precision
Effortlessly streamline DNA extraction with CB™ Magnetic-Nanoparticle Systems.
Stable Cell Line Generation
Reliable | Scalable | Customizable
Fast proposals, regular updates, and detailed reports; strict quality control, and contamination-free cells; knockout results in 4-6 weeks.
Target-based Drug Discovery Service
Innovative | Comprehensive | Efficient
Target identification, validation, and screening for drug discovery and therapeutic development.
Custom Viral Service
Versatile | High-Yield | Safe
Unbeatable pricing, fully customizable viral packaging services (covering 30,000+ human genes, 200+ mammals, 50+ protein tags).
Custom Antibody Service
Precise | Flexible | Efficient
End-to-end antibody development support, from target to validation, enabling clients to rapidly obtain application-ready antibodies.
Antibody-Drug Conjugation Service
Integrated | Controlled | Translational
Comprehensive solutions covering design, development, and validation to ensure conjugated drugs with consistent quality and clinical potential.
Protein Degrader Service
Efficient | High-Precision | Advanced Therapeutics
Harness the power of protein degraders for precise protein degradation, expanding druggable targets and enhancing therapeutic effectiveness for cutting-edge drug discovery.
Nucleotides Service
Accurate | Flexible | High-Quality
Custom synthesis of oligonucleotides, primers, and probes for gene editing, PCR, and RNA studies.
Custom RNA Service
Custom RNA ServicePrecise | Flexible | GMP-ReadyCustom
RNA design, synthesis, and manufacturing—covering mRNA, saRNA, circRNA, and RNAi. Fast turnaround, rigorous QC, and seamless transition from research to GMP production.
Custom Libraries Construction Service
Comprehensive | High-throughput | Accurate
Custom cDNA, genomic, and mutagenesis libraries for drug discovery, screening, and functional genomics.
Gene Editing Services
Precise | Efficient | Targeted
Gene editing solutions for gene editing, knockouts, knock-ins, and customized genetic modifications. Integrated multi-platform solutions for one-stop CRISPR sgRNA library synthesis and gene screening services
Microbe Genome Editing Service
Precise | Scalable | Customizable
Enhance microbial productivity with advanced genome editing using Rec-mediated recombination and CRISPR/Cas9 technologies.
Biosafety Testing Service
Reliable | Comprehensive | Regulated
Complete biosafety testing solutions for gene therapy, viral vectors, and biologics development.
Plant Genetic Modification Service
Advanced | Sustainable | Tailored
Genetic modification for crop improvement, biotechnology, and plant-based research solutions.
Plant-based Protein Production Service
Efficient | Scalable | Customizable
Plant-based protein expression systems for biopharmaceuticals, enzyme production, and research.
Aptamers Service
Innovative | Fast | Cost-Effective
Revolutionizing drug delivery and diagnostic development with next-generation high-throughput aptamer selection and synthesis technologies.
CGT Biosafety Testing
Comprehensive | Accurate | Regulatory-compliant
Internationally certified evaluation system for biologics, gene therapies, nucleic acid drugs, and vaccines.
Pandemic Detection Solutions
Rapid | Precise | Scalable
Balancing accuracy, accessibility, affordability, and rapid detection to safeguard public health and strengthen global response to infectious diseases.
cGMP Cell Line Development
Reliable | Scalable | Industry-leading
Stable expression over 15 generations with rapid cell line development in just 3 months.
Supports adherent and suspension cell lines, offering MCB, WCB, and PCB establishment.
GMP mRNA Production
Efficient | Scalable | Precise
Scalable mRNA production from milligrams to grams, with personalized process design for sequence optimization, cap selection, and nucleotide modifications, all in one service.
GMP Plasmid Production
High Quality | Scalable | Regulatory-compliant
Our plasmid production services span Non-GMP, GMP-Like, and GMP-Grade levels, with specialized options for linearized plasmids.
GMP Viral Vector Manufacturing
Scalable | High Yield | Quality-driven
Advanced platforms for AAV, adenovirus, lentivirus, and retrovirus production, with strict adherence to GMP guidelines and robust quality control.
AI-Driven Gene Editing and Therapy
Innovative | Precision | Transformative
AI-powered one-click design for customized CRISPR gene editing strategy development.
AI-Antibody Engineering Fusion
Next-Generation | Targeted | Efficient
AI and ML algorithms accelerate antibody screening and predict new structures, unlocking unprecedented possibilities in antibody engineering.
AI-Driven Enzyme Engineering
Smart | Efficient | Tailored
High-throughput enzyme activity testing with proprietary datasets and deep learning models for standardized and precise enzyme engineering design.
AI-Enhanced Small Molecule Screening
Predictive | Efficient | Insightful
Leverage AI to uncover hidden high-potential small molecules, prioritize leads intelligently, and reduce costly trial-and-error in early drug discovery.
AI-Driven Protein Degrader Drug Development
Innovative | Targeted | Accelerated
Use AI-guided design to optimize protein degraders, addressing design complexity and enhancing efficacy while shortening development timelines.
| Cat.No. | Product Name | Price |
|---|
| Cat.No. | Product Name | Price |
|---|
| Cat.No. | Product Name | Price |
|---|
| Cat.No. | Product Name | Price |
|---|
The Maf family protein is derived from the original member of the family, v-Maf, a protein encoded by the avian musculoaponeurotic fibrosarcoma virus (AS42) oncogene v-maf. Maf can bind to other family transcription factors containing b-Zip motifs in the nucleus to form homologous or heterodimers, and then bind to the specific sequence Mafre recognition elements (MARE) on DNA to regulate the corresponding Gene transcription. Later, many structurally similar Maf family proteins were found, including large Maf family proteins (greater than 200 amino acid residues) c-Maf, MafB, MafA/L-Maf/SMaf, Nrl and small Maf family proteins (less than 200 amino acid residues) MafK, MafF, MafG, and MafT. Maf family proteins play a key role in the proliferation, metastasis and differentiation of embryonic maternal erythrocytes, the development of eye lens, the polarization of Th2 cells, insulin production, and apoptosis.
Maf Structure
At present, several Maf family genes have been cloned in different species, including humans, mice, clawed frogs, chickens and zebrafish. The Maf family encodes a protein with a highly conserved basic region, a bZIP domain at the carboxy terminus that binds the Maf protein to its target DNAs, typically through a T-MARE or C-MARE recognition site. The bZIP that binds to the Maf protein can also form a dimer with itself or other proteins containing the bZIP domain.

Figure 1. A LncRNA-MAF:MAFB Transcription Factor Network Regulates Epidermal Differentiation. (Lopez-Pajares, et al. 2015)
The function of the Maf
MafB is selectively expressed in monocytes and macrophages. For example, during macrophage differentiation, MafB is not expressed in pluripotent progenitor cells, expressed at appropriate levels in myeloid bud cells, and expressed at high levels in mature monocytes and macrophages. Further studies have shown that MafB can bind to the promoter of macrophage growth factor f4/80, which also has a MARE semi-similar sequence on the promoter to promote its expression. If MafB is absent, the expression of f4/80 will also be inhibited. Other studies have shown that when alveolar macrophages are subjected to oxidative stress by free radicals, oxidants and lipid peroxides, their function changes and their survival is prolonged. In the study of numerous transcription factors inside alveolar macrophages, only MafB expression was up-regulated and it was responsible for inhibiting apoptosis of macrophages.
MafB also plays an important role in the differentiation and development of islet α cells and β cells. Embryonic MafB is expressed in both α cells and β cells. If MafB is mutated during embryonic stage, the number of insulin cells and glucagon cells is reduced. MafB expression was reduced in beta cells after birth, and MafB was not detected after 3 weeks. After maturity, MafB is expressed only in the alpha cells of islets, selectively binding to the G1 control region of the glucagon gene, regulating the activation of the glucagon gene.
ELMO1(engulfment and cell motility 1) and tumor invasive growth
Other small Maf family proteins were found in the defense response of the studied cells. When cells are stimulated by certain chemicals, oxidants, and antioxidants, Keap1 (Kelch-like ECH-associated protein 1) first senses these substances and resolves with Nrf2. Dissociated Nrf2 accumulates in the nucleus and forms a heterodimer with the small Maf proteins MafG and MafK in the nucleus, and then binds to the antioxidant response element ARE, ultimately regulating the ARE-dependent phase II detoxification enzyme gene and antioxidant The transcription of the genes NQO1, GSTYa, g-GCS, HO-1 and ferritin-L has extensive cytoprotective functions in anti-tumor, neuroprotective, and anti-inflammatory responses. Overexpression of MafG and MafK can inhibit the transcription of genes such as NQO1, GSTYa, and g-GCS.
References:
Contact us today for a free consultation with the scientific team and discover how Creative Biogene can be a valuable resource and partner for your organization.
Inquiry
Copyright © Creative Biogene. All rights reserved.